Format

Send to

Choose Destination
Cancer Treat Res. 2018;173:167-189. doi: 10.1007/978-3-319-70197-4_11.

Sexual Function Post-Breast Cancer.

Author information

1
The Northwestern Medicine Center for Sexual Medicine and Menopause, Feinberg School of Medicine, Chicago, USA. lstreicher@nm.org.
2
The Northwestern Medicine Center for Sexual Medicine and Menopause, Feinberg School of Medicine, Chicago, USA.
3
George Washington University, Washington, USA.

Abstract

The consequences of estrogen deprivation and therapeutic interventions such as radiation, chemotherapy and surgery have a significant negative impact on libido, sexual arousal, orgasmic function and the ability to have pleasurable intercourse. Evaluation and treatment of female sexual dysfunction is a significant unmet need in the breast cancer survivor in spite of the availability of safe and effective treatments.

KEYWORDS:

DHEA; Dyspareunia; Female sexual dysfunction; Fractional CO2 laser; Genitourinary syndrome of menopause; Hypoactive sexual desire disorder; Ospemifene; Prasterone; Vaginal estrogen

PMID:
29349764
DOI:
10.1007/978-3-319-70197-4_11
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center